AEON Biopharma (AEON) vs Optimi Health (OPTH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
AEON Biopharma is the larger company by market cap ($10.3 million vs $8.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AEON | OPTH |
|---|---|---|
| Share price | $0.123 | $1.51 |
| Market cap | $10.35M | $8.65M |
| 1-day change | -7.59% | -13.71% |
| YTD return | -88.82% | — |
| 1-year return | -85.18% | — |
| EPS (TTM) | $-3.89 | $-1.56 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-39.22M | — |
| 52-week high | $1.45 | $6.40 |
| 52-week low | $0.106 | $1.51 |
| Distance from 52-week high | -91.52% | -76.41% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +1379.67% | — |
| Average volume | 7.44M | 43.55K |
| Shares outstanding | 84.12M | 5.73M |
| Employees | 8 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About AEON Biopharma
AEON stock →AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine.
Health Care · Biotechnology: Pharmaceutical Preparations · 8 employees
About Optimi Health
OPTH stock →Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.
Health Care · Biotechnology: Pharmaceutical Preparations
AEON vs OPTH FAQ
Which is bigger, AEON Biopharma or Optimi Health?
AEON Biopharma (AEON) is larger, with a market capitalization of $10.35M compared with $8.65M for Optimi Health (OPTH).
Are AEON Biopharma and Optimi Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.